ReleaseWire Connect

HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and HIV-associated Lipodystrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of HIV-associated Lipodystrophy till 2023.

Orthodontics is a vital component of restorative or cosmetic dentistry. It deals with the treatment of malocclusions (improper alignment and bites) caused due to tooth irregularity, inappropriate jaw alignment, and gaps in teeth. Orthodontics can be classified into the following: clear aligners, ceramic braces, and lingual braces.

The global dermatology diagnostic devices market is dominated by microscopes with a market share of 34% owing to its convenience in use. They are used in almost every skin diagnostic procedures to identify the skin condition/ailment. Technological improvements in the field of microscopy are focused on enhancing the accuracy and sensitivity of the detection mechanisms. Also, the rise in skin disorders such as melanoma, dermatitis, immune disorders, and infections has a significant impact on the market growth. For instance, according to Centers for Disease Control and Prevention (CDC), around 72,500 people in the US were diagnosed with melanoma skin disorder of which 30,000 were women and 42,500 were men.

CNS disorders can affect either the brain or spinal cord, or both. CNS disorders are also called as neurological and psychiatric disorders. The major causes of CNS disorders are infections, trauma, degeneration, structural defects, tumors, autoimmune disorders, and stroke. A headache, muscle weakness, memory loss, impaired mental ability, and lack of coordination are few of the symptoms of CNS disorders.

Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is the most common and aggressive human brain tumor, accounting for 15.4% of all primary brain tumors and 60-75% of all astrocytomas. It has a peak incidence between 55 and 84 years of age, with the median age of diagnosis being 64 years. In the US and EU, the annual incidence was estimated to be three to four cases per 100,000 people. GBM has a high degree of intratumoral heterogeneity, which is associated with poor prognosis and the development of drug resistance.

BDM tests assist medical practitioners in predicting the fracture risk of individuals by analyzing the composition of bones, including calcium and minerals. BDM devices are used as a non-invasive method of performing these tests that provide the quantitative measurement of bone mass or density. BDM devices are generally used in measuring bone mass, body composition, the risk of fracture, and pediatric development. The device is used to diagnose bone loss and osteoporosis, regulate the progress of osteoporosis medicine, and predict the risk of future bone fractures.

Provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies.

"Hyperthyroidism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hyperthyroidism Report is to understand the market and pipeline status of the drugs around the Hyperthyroidism to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hyperthyroidism. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

"Dysuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dysuria Report is to understand the market and pipeline status of the drugs around the Dysuria to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Dysuria. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

"Narcolepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Narcolepsy Report is to understand the market and pipeline status of the drugs around the Narcolepsy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Narcolepsy. While the leading brands, companies and chemicals are considered thoroughly, Report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.